Skip to main content
Thorax logoLink to Thorax
. 1978 Oct;33(5):635–637. doi: 10.1136/thx.33.5.635

Reversibility of airways obstruction in bronchiectasis.

S G Nogrady, W V Evans, B H Davies
PMCID: PMC470949  PMID: 725832

Abstract

Patients with airways obstruction and bronchiectasis were investigated for features of allergic disease and for reversibility of airways obstruction in respinse to inhaled and intravenous salbutamol. There was a 26% increase in PEFR and a 16% increase in FEV1 after inhaled salbutamol, and the response to the intravenous drug was not significantly better than that to the inhaled. Those patients who responded to bronchodilators could not be identified by clinical or immunological features.

Full text

PDF
635

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cherniack N. S., Carton R. W. Factors associated with respiratory insufficiency in bronchiectasis. Am J Med. 1966 Oct;41(4):562–571. doi: 10.1016/0002-9343(66)90218-x. [DOI] [PubMed] [Google Scholar]
  2. HUME K. M., GANDEVIA B. Forced expiratory volume before and after isoprenaline. Thorax. 1957 Sep;12(3):276–278. doi: 10.1136/thx.12.3.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Pande J. N., Jain B. P., Gupta R. G., Guleria J. S. Pulmonary ventilation and gas exchange in bronchiectasis. Thorax. 1971 Nov;26(6):727–733. doi: 10.1136/thx.26.6.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. SANERKIN N. G., EVANS D. M. THE SPUTUM IN BRONCHIAL ASTHMA: PATHOGNOMONIC PATTERNS. J Pathol Bacteriol. 1965 Apr;89:535–541. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES